JP2024502309A5 - - Google Patents
Info
- Publication number
- JP2024502309A5 JP2024502309A5 JP2023539145A JP2023539145A JP2024502309A5 JP 2024502309 A5 JP2024502309 A5 JP 2024502309A5 JP 2023539145 A JP2023539145 A JP 2023539145A JP 2023539145 A JP2023539145 A JP 2023539145A JP 2024502309 A5 JP2024502309 A5 JP 2024502309A5
- Authority
- JP
- Japan
- Prior art keywords
- microcrystalline cellulose
- cannabinoid oil
- composition according
- oil
- cannabinoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135198P | 2021-01-08 | 2021-01-08 | |
| US63/135,198 | 2021-01-08 | ||
| PCT/EP2021/087505 WO2022148672A1 (en) | 2021-01-08 | 2021-12-23 | Oral solid cannabinoid oil composition for treating central nervous system disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502309A JP2024502309A (ja) | 2024-01-18 |
| JP2024502309A5 true JP2024502309A5 (https=) | 2024-12-12 |
Family
ID=79731086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023539145A Withdrawn JP2024502309A (ja) | 2021-01-08 | 2021-12-23 | 中枢神経系障害を治療するための経口用固形カンナビノイド油組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240050377A1 (https=) |
| EP (1) | EP4274554A1 (https=) |
| JP (1) | JP2024502309A (https=) |
| CN (1) | CN116546983A (https=) |
| AU (1) | AU2021417405A1 (https=) |
| CA (1) | CA3200382A1 (https=) |
| WO (1) | WO2022148672A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8808736B2 (en) * | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
| CA2909591C (en) * | 2013-04-23 | 2017-03-28 | Zx Pharma, Llc | Enteric coated multiparticulate composition with proteinaceous subcoat |
| WO2019159174A1 (en) * | 2018-02-16 | 2019-08-22 | Icdpharma Ltd. | Colonic delivery of cannabinoids in solid solution compositions |
| WO2020016656A2 (en) * | 2018-07-18 | 2020-01-23 | Glatt Gmbh | Extended release formulations of cannabinoids |
| CA3140813A1 (en) * | 2019-06-13 | 2021-12-07 | Imbucanna, Inc | Compressible cannabinoid pharmaceutical composition |
| EP4087547A1 (en) * | 2020-01-08 | 2022-11-16 | Société des Produits Nestlé S.A. | Oral solid cannabinoid oil composition for treating gastrointestinal disorders |
-
2021
- 2021-12-23 AU AU2021417405A patent/AU2021417405A1/en active Pending
- 2021-12-23 WO PCT/EP2021/087505 patent/WO2022148672A1/en not_active Ceased
- 2021-12-23 US US18/260,276 patent/US20240050377A1/en active Pending
- 2021-12-23 CN CN202180083871.2A patent/CN116546983A/zh not_active Withdrawn
- 2021-12-23 CA CA3200382A patent/CA3200382A1/en active Pending
- 2021-12-23 EP EP21845023.7A patent/EP4274554A1/en active Pending
- 2021-12-23 JP JP2023539145A patent/JP2024502309A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19940944B4 (de) | Retardierte, orale, pharmazeutische Darreichungsformen | |
| JP2023509675A5 (https=) | ||
| HU226116B1 (en) | Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor | |
| RU99126869A (ru) | Фармацевтический препарат омепразола | |
| EP3154523A1 (en) | Formulation for oral administration containing mesalazine | |
| WO2001015683A1 (de) | Retardierte darreichungsform enthaltend tramadolsaccharinat | |
| US10874617B2 (en) | Oral pharmaceutical compositions of mesalazine | |
| KR20040031019A (ko) | 루미라콕시브를 포함하는 제약 조성물 | |
| JP2024502309A5 (https=) | ||
| EP3445360B1 (en) | Oral pharmaceutical compositions of nicotinamide | |
| JP2023509675A (ja) | 胃腸障害を治療するための経口用固形カンナビノイド油組成物 | |
| CA3160869C (en) | Dosage form for use in treating or preventing of a disease | |
| EP0896530B1 (en) | Dosage forms and uses | |
| SI21301A (sl) | Farmacevtska oblika z nadzorovanim sproščanjem | |
| WO2008041073A2 (en) | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof | |
| CN103520136A (zh) | 孟鲁斯特钠脉冲胶囊及其制备方法 | |
| DE19920415A1 (de) | Metamizol enthaltende, kontrolliert freisetzende pharmazeutische Zusammensetzung | |
| TW200305443A (en) | Pharmaceutical compositions | |
| CN101987092A (zh) | 含有镇痛剂的新型药学组成物 | |
| JP2024502309A (ja) | 中枢神経系障害を治療するための経口用固形カンナビノイド油組成物 | |
| WO2007138557A2 (en) | Controlled-release multiple unit pharmaceutical compositions | |
| JP2022506007A (ja) | ミコフェノール酸活性剤を非ヒト哺乳動物に送達するための方法および組成物 | |
| JP2006160659A (ja) | テオフィリン徐放性微粒子の製造方法 | |
| WO2018087109A1 (de) | Multipartikuläre arzneiform mit kontrollierter freisetzung von metamizol | |
| HK40005191B (en) | Oral pharmaceutical compositions of nicotinamide |